Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study

BACKGROUND: Combination chemotherapy is used to treat advanced thymic carcinoma; however, the effects are insufficient. METHODS: Previously untreated patients with unresectable locally advanced thymic carcinoma received two cycles of 80 mg/m(2)/day S‐1 orally on days 1–14 plus 60 mg/m(2)/day cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Minoru, Yamaguchi, Masafumi, Yamazaki, Takuya, Funaki, Soichiro, Mukae, Hiroshi, Fukuoka, Junya, Nabeshima, Kazuki, Tateyama, Hisashi, Ashizawa, Kazuto, Tomiyama, Noriyuki, Hara, Masaki, Seto, Takashi, Okumura, Meinoshin, Sugio, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436693/
https://www.ncbi.nlm.nih.gov/pubmed/35869676
http://dx.doi.org/10.1111/1759-7714.14586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436693/
https://www.ncbi.nlm.nih.gov/pubmed/35869676
http://dx.doi.org/10.1111/1759-7714.14586

Ejemplares similares